ACADIA Pharmaceuticals Inc
ACAD
$19.12-2.99%
End of day · as of Oct 17, 2026, 8:00 AM ET
Mkt cap
$3.51B
EV/Sales
3.11
P/E ratio
N/A
FY2025 Revenue
$1.07B
EPS (TTM)
$2.23
Gross Margin (FY2025)
91.69%
Profit Margin (FY2025)
36.49%
Beta
0.65
Div yield
N/A
Sector
Healthcare
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Latest reported ACAD revenue for 2025-12-31 was $1.07B. Net income was $391.0M. Revenue was up 11.9% from 2024-12-31 to 2025-12-31. ACAD currently screens at market cap $3.51B.
Use this ACAD research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ACAD income, balance, and cash tables.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company in the Healthcare sector.
Latest cached ACADIA Pharmaceuticals Inc (ACAD) revenue for Dec 31, 2025 was $1.07B. Net income was $391.0M. Statements: https://lician.com/financials/acad
ACADIA Pharmaceuticals Inc (ACAD) market capitalization is $3.51B on the latest cached snapshot.
ACADIA Pharmaceuticals Inc (ACAD) cached previous close $19.71; day range $19.12 – $19.76; volume 1,626,069. Session quote: https://lician.com/quote/acad
ACADIA Pharmaceuticals Inc (ACAD) latest cached earnings event is "ACAD earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ACAD filing is 8-K · Oct 23, 2026. Filings: https://lician.com/sec/acad